For laboratory research use only. Not for human or veterinary use.
Retatrutide is a synthetic peptide studied for triple receptor pathway activity involving GLP-1, GIP, and glucagon receptor systems.
| Total Content | Volume | Concentration | 0.1 mL | 0.2 mL | 0.4 mL | 1.0 mL |
|---|---|---|---|---|---|---|
| 10mg | 2mL | 10mg/mL | 1mg | 2mg | 4mg | 10mg |
| 20mg | 2mL | 10mg/mL | 1mg | 2mg | 4mg | 10mg |
View the available analysis report for this product.
Quantified to verify concentration within accepted labeled specification.
Assessed for peptide purity and absence of significant impurities by analytical methods.
Confirmed by analytical testing to match reference peptide characteristics.
Batch records and test data maintained for traceability and transparency.
Tirzepatide is studied for dual GIP and GLP-1 activity. Retatrutide is studied for triple pathway activity involving GLP-1, GIP, and glucagon receptors.
It is commonly studied in metabolic signaling, glucose-response models, appetite signaling, and energy-balance research.
No. This product is supplied strictly for laboratory research use only and is not intended for human or veterinary use.